{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:44:11Z","timestamp":1791927851866,"version":"4.3.4"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["(Grant numbers [71067])"],"award-info":[{"award-number":["(Grant numbers [71067])"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.TBZMED.REC.1402.360. JS"],"award-info":[{"award-number":["IR.TBZMED.REC.1402.360. JS"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00284-024-03997-y","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:25:19Z","timestamp":1732613119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Recent Advances in Gut Microbiome Modulation: Effect of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Inflammatory Bowel Disease Prevention and Treatment"],"prefix":"10.1007","volume":"82","author":[{"given":"Samira","family":"Saedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safoura","family":"Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manouchehr","family":"Khoshbaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahdat","family":"Poortahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam Gonbari","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"issue":"4","key":"3997_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ame2.12255","volume":"5","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Si X, Yang L, Wang H, Sun Y, Liu N (2022) Association between intestinal microbiota and inflammatory bowel disease. Animal Models and Exp Med 5(4):311\u2013322","journal-title":"Animal Models and Exp Med"},{"issue":"1","key":"3997_CR2","first-page":"26","volume":"16","author":"SH Lee","year":"2018","unstructured":"Lee SH et al (2018) Immunological pathogenesis of inflammatory bowel disease. Int Res 16(1):26\u201342","journal-title":"Int Res"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/dmr-21-1","volume":"4","author":"L Kellermann","year":"2021","unstructured":"Kellermann L, Riis LB (2021) A close view on histopathological changes in inflammatory bowel disease, a narrative review. Digestive Med Res 4:3","journal-title":"Digestive Med Res"},{"key":"3997_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-019-0963-7","volume":"19","author":"BK Perler","year":"2019","unstructured":"Perler BK, Ungaro R, Baird G, Mallette M, Bright R, Shah S, Shapiro J, Sands BE (2019) Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol 19:1\u20138","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"3997_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/nu12040944","volume":"12","author":"MC Mentella","year":"2020","unstructured":"Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD (2020) Nutrition, IBD and gut microbiota: a review. Nutrients 12(4):944","journal-title":"Nutrients"},{"issue":"15","key":"3997_CR6","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.3390\/jcm12155142","volume":"12","author":"P Danpanichkul","year":"2023","unstructured":"Danpanichkul P, Suparan K, Arayakarnkul S, Jaroenlapnopparat A, Polpichai N, Fangsaard P, Kongarin S, Srisurapanont K, Sukphutanan B, Wanchaitanawong W (2023) Global epidemiology and burden of elderly-onset inflammatory bowel disease: a decade in review. J Clin Med 12(15):5142","journal-title":"J Clin Med"},{"issue":"2","key":"3997_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2018.1463897","volume":"6","author":"AN Anbazhagan","year":"2018","unstructured":"Anbazhagan AN, Priyamvada S, Alrefai WA, Dudeja PK (2018) Pathophysiology of IBD associated diarrhea. Tissue barriers 6(2):e1463897. https:\/\/doi.org\/10.1080\/21688370.2018.1463897","journal-title":"Tissue barriers"},{"issue":"3","key":"3997_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jgh.14872","volume":"35","author":"WY Mak","year":"2020","unstructured":"Mak WY, Zhao M, Ng SC, Burisch J (2020) The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol 35(3):380\u2013389","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"3997_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P (2022) The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J 10(10):1063\u20131076. https:\/\/doi.org\/10.1002\/ueg2.12350","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"3997_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-019-0341-6","volume":"12","author":"MT Alam","year":"2020","unstructured":"Alam MT, Amos GC, Murphy AR, Murch S, Wellington EM, Arasaradnam RP (2020) Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut pathogens 12(1):1\u20138","journal-title":"Gut pathogens"},{"issue":"12","key":"3997_CR11","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/microorganisms10122405","volume":"10","author":"J Talapko","year":"2022","unstructured":"Talapko J, V\u010dev A, Me\u0161trovi\u0107 T, Pustijanac E, Juki\u0107 M, \u0160krlec I (2022) Homeostasis and dysbiosis of the intestinal microbiota: comparing hallmarks of a healthy state with changes in inflammatory bowel disease. Microorganisms 10(12):2405","journal-title":"Microorganisms"},{"key":"3997_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7080271","author":"S Lobionda","year":"2019","unstructured":"Lobionda S, Sittipo P, Kwon HY (2019) The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms7080271","journal-title":"Microorganisms"},{"key":"3997_CR13","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i2.321","author":"L Zheng","year":"2021","unstructured":"Zheng L, Wen XL (2021) Gut microbiota and inflammatory bowel disease: the current status and perspectives. World J Clin Cases. https:\/\/doi.org\/10.12998\/wjcc.v9.i2.321","journal-title":"World J Clin Cases"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3389\/fphar.2018.01571","volume":"9","author":"PJ Basso","year":"2019","unstructured":"Basso PJ, C\u00e2mara NOS, Sales-Campos H (2019) Microbial-based therapies in the treatment of inflammatory bowel disease\u2013an overview of human studies. Front Pharmacol 9:1571","journal-title":"Front Pharmacol"},{"issue":"1","key":"3997_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.14384","volume":"47","author":"J McIlroy","year":"2018","unstructured":"McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold G (2018) the gut microbiome in inflammatory bowel disease\u2014avenues for microbial management. Aliment Pharmacol Ther 47(1):26\u201342","journal-title":"Aliment Pharmacol Ther"},{"key":"3997_CR16","first-page":"101","volume":"10","author":"S Guandalini","year":"2019","unstructured":"Guandalini S, Sansotta N (2019) Probiotics in the treatment of inflammatory bowel disease. Probiotics and Child Gastrointestinal Health: Adv Microbiol, Infect Dis Public Health 10:101\u2013107","journal-title":"Probiotics and Child Gastrointestinal Health: Adv Microbiol, Infect Dis Public Health"},{"key":"3997_CR17","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/febs.16705","volume":"291","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang H, Xu T, Zeng L, Liu F, Huang X, Liu Q (2022) Interactions among microorganisms open up a new world for anti-infectious therapy. The FEBS J 291:1615\u20131631","journal-title":"The FEBS J"},{"issue":"6","key":"3997_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30(6):492\u2013506","journal-title":"Cell Res"},{"issue":"1","key":"3997_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS (2022) Microbiota in health and diseases. Signal Trans Targ Ther 7(1):135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4","journal-title":"Signal Trans Targ Ther"},{"key":"3997_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247238","author":"Q Guan","year":"2019","unstructured":"Guan Q (2019) A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. https:\/\/doi.org\/10.1155\/2019\/7247238","journal-title":"J Immunol Res"},{"key":"3997_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.imj.2022.08.004","author":"B Madhogaria","year":"2022","unstructured":"Madhogaria B, Bhowmik P, Kundu A (2022) Correlation between human gut microbiome and diseases. Infect Med. https:\/\/doi.org\/10.1016\/j.imj.2022.08.004","journal-title":"Infect Med"},{"key":"3997_CR22","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R036012","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. https:\/\/doi.org\/10.1194\/jlr.R036012","journal-title":"J Lipid Res"},{"key":"3997_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112352","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Dehkhodaie E, Bouzari B, Rahimi M, Gholestani A, Hosseini-Fard SR, Keyvani H, Teimoori A, Karampoor S (2022) Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.112352","journal-title":"Biomed Pharmacother"},{"key":"3997_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051533","author":"K Sugihara","year":"2021","unstructured":"Sugihara K, Kamada N (2021) Diet-microbiota interactions in inflammatory bowel disease. Nutrients. https:\/\/doi.org\/10.3390\/nu13051533","journal-title":"Nutrients"},{"issue":"1","key":"3997_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000525925","volume":"104","author":"A Andoh","year":"2023","unstructured":"Andoh A, Nishida A (2023) Alteration of the gut microbiome in inflammatory bowel disease. Digestion 104(1):16\u201323","journal-title":"Digestion"},{"key":"3997_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073464","author":"PT Santana","year":"2022","unstructured":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP (2022) Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073464","journal-title":"Int J Mol Sci"},{"key":"3997_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974305","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Liu T, Gu Y, Wang X, Xie R, Sun Y, Wang B, Cao H (2022) Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease. Front Immunol 13:974305","journal-title":"Front Immunol"},{"issue":"1","key":"3997_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol 10(1):18\u201326. https:\/\/doi.org\/10.1038\/mi.2016.75","journal-title":"Mucosal Immunol"},{"key":"3997_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MBP-0008-2014","author":"B Stecher","year":"2015","unstructured":"Stecher B (2015) The roles of inflammation, nutrient availability and the commensal microbiota in enteric pathogen infection. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MBP-0008-2014","journal-title":"Microbiol Spectr"},{"issue":"2","key":"3997_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/sjg.sjg_368_22","volume":"29","author":"H Al-Amrah","year":"2023","unstructured":"Al-Amrah H, Saadah OI, Mosli M, Annese V, Al-Hindi R, Edris S, Alshehri D, Alatawi H, Alatawy M, Bahieldin A (2023) Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: a pilot study. Saudi J Gastroenterol 29(2):102\u2013110","journal-title":"Saudi J Gastroenterol"},{"key":"3997_CR31","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.afres.2022.100185","volume":"2","author":"TK Das","year":"2022","unstructured":"Das TK, Pradhan S, Chakrabarti S, Mondal KC, Ghosh K (2022) Current status of probiotic and related health benefits. Appl Food Res 2:100185","journal-title":"Appl Food Res"},{"key":"3997_CR32","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3389\/fphar.2018.01571","volume":"9","author":"PJ Basso","year":"2018","unstructured":"Basso PJ, C\u00e2mara NOS, Sales-Campos H (2018) Microbial-based therapies in the treatment of inflammatory bowel disease\u2014An overview of human studies. Front Pharmacol 9:1571. https:\/\/doi.org\/10.3389\/fphar.2018.01571","journal-title":"Front Pharmacol"},{"issue":"1","key":"3997_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/09637486.2018.1477123","volume":"70","author":"AY Coqueiro","year":"2019","unstructured":"Coqueiro AY, Raizel R, Bonvini A, Tirapegui J, Rogero MM (2019) Probiotics for inflammatory bowel diseases: a promising adjuvant treatment. Int J Food Sci Nutr 70(1):20\u201329. https:\/\/doi.org\/10.1080\/09637486.2018.1477123","journal-title":"Int J Food Sci Nutr"},{"key":"3997_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu12071973","author":"D Jakubczyk","year":"2020","unstructured":"Jakubczyk D, Leszczy\u0144ska K (2020) The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)-A critical review. Nutrients. https:\/\/doi.org\/10.3390\/nu12071973","journal-title":"Nutrients"},{"issue":"4","key":"3997_CR35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.gtc.2017.08.003","volume":"46","author":"BP Abraham","year":"2017","unstructured":"Abraham BP, Quigley EM (2017) Probiotics in inflammatory bowel disease. Gastroenterol Clin 46(4):769\u2013782","journal-title":"Gastroenterol Clin"},{"key":"3997_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010184","author":"C Mazziotta","year":"2023","unstructured":"Mazziotta C, Tognon M (2023) Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. https:\/\/doi.org\/10.3390\/cells12010184","journal-title":"Cells"},{"key":"3997_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102652","volume":"78","author":"VD Bamola","year":"2022","unstructured":"Bamola VD, Dubey D, Samanta P, Kedia S, Ahuja V, Madempudi RS, Neelamraju J, Chaudhry R (2022) Role of a probiotic strain in the modulation of gut microbiota and cytokines in inflammatory bowel disease. Anaerobe 78:102652","journal-title":"Anaerobe"},{"key":"3997_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clnesp.2022.08.020","volume":"51","author":"LM Agraib","year":"2022","unstructured":"Agraib LM, Yamani MI, Tayyem R, Abu-Sneineh AT, Rayyan YM (2022) Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: a pilot, randomized, double-blind, placebo-controlled study. Clin Nutr ESPEN 51:83\u201391","journal-title":"Clin Nutr ESPEN"},{"key":"3997_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clnesp.2022.08.020","volume":"51","author":"LM Agraib","year":"2022","unstructured":"Agraib LM, Yamani MI, Tayyem R, Abu-Sneineh AT, Rayyan YM (2022) Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: a pilot, randomized, double-blind, placebo-controlled study. Clin Nutr ESPEN 51:83\u201391. https:\/\/doi.org\/10.1016\/j.clnesp.2022.08.020","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"3997_CR40","doi-asserted-by":"publisher","first-page":"e00657","DOI":"10.1128\/spectrum.00657-22","volume":"10","author":"L Xu","year":"2022","unstructured":"Xu L, Liu B, Huang L, Li Z, Cheng Y, Tian Y, Pan G, Li H, Xu Y, Wu W (2022) Probiotic consortia and their metabolites ameliorate the symptoms of inflammatory bowel diseases in a colitis mouse model. Microbiology spectrum 10(4):e00657\u2013e00622","journal-title":"Microbiology spectrum"},{"issue":"8","key":"3997_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.5152\/tjg.2019.18426","volume":"30","author":"H Fan","year":"2019","unstructured":"Fan H, Du J, Liu X, Zheng WW, Zhuang ZH, Wang CD, Gao R (2019) Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease. The Turkish J Gastroenterol: The Off J Turkish Soc Gastroenterol 30(8):680\u2013685. https:\/\/doi.org\/10.5152\/tjg.2019.18426","journal-title":"The Turkish J Gastroenterol: The Off J Turkish Soc Gastroenterol"},{"issue":"3","key":"3997_CR42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5152\/tjg.2018.18227","volume":"30","author":"\u0130 Y\u0131lmaz","year":"2019","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H (2019) Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. The Turkish J Gastroenterol: The Off J Turkish Soc Gastroenterol 30(3):242\u2013253. https:\/\/doi.org\/10.5152\/tjg.2018.18227","journal-title":"The Turkish J Gastroenterol: The Off J Turkish Soc Gastroenterol"},{"issue":"7","key":"3997_CR43","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s10620-018-4946-2","volume":"63","author":"K Matsuoka","year":"2018","unstructured":"Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, Yoshimura N, Hibi T (2018) Efficacy of bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis. Dig Dis Sci 63(7):1910\u20131919. https:\/\/doi.org\/10.1007\/s10620-018-4946-2","journal-title":"Dig Dis Sci"},{"key":"3997_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6882-10-13","volume":"10","author":"H Matthes","year":"2010","unstructured":"Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J (2010) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 10:13. https:\/\/doi.org\/10.1186\/1472-6882-10-13","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"3997_CR45","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1002\/iid3.635","volume":"10","author":"S Aghamohammad","year":"2022","unstructured":"Aghamohammad S, Sepehr A, Miri ST, Najafi S, Pourshafie MR, Rohani M (2022) Anti-inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control. Immun, Inflamm Dis 10(6):e635","journal-title":"Immun, Inflamm Dis"},{"issue":"1","key":"3997_CR46","first-page":"5","volume":"87","author":"A Khramtsov","year":"2017","unstructured":"Khramtsov A, Ryabtseva S, Budkevich R, Akhmedova V, Rodnaya A, Marugina E (2017) Prebiotics as functional food ingredients: terminology, choice and comparative evaluation criteria, classification. Vopr Pitan 87(1):5\u201317","journal-title":"Vopr Pitan"},{"issue":"9","key":"3997_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/nu9091021","volume":"9","author":"P Markowiak","year":"2017","unstructured":"Markowiak P, \u015ali\u017cewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):1021","journal-title":"Nutrients"},{"issue":"8","key":"3997_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G (2017) Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3997_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jiac.2020.01.006","volume":"26","author":"S Komaki","year":"2020","unstructured":"Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S (2020) Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 26(6):549\u2013553","journal-title":"J Infect Chemother"},{"issue":"2","key":"3997_CR50","first-page":"e100055","volume":"2","author":"A Ariaee","year":"2024","unstructured":"Ariaee A, Koentgen S, Wardill HR, Hold GL, Prestidge CA, Armstrong HK, Joyce P (2024) Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence. Gastroenterology 2(2):e100055","journal-title":"Gastroenterology"},{"key":"3997_CR51","doi-asserted-by":"crossref","unstructured":"Valcheva R, Armstrong H, Kovic O, Bording-Jorgensen M, Veniamin S, P\u00e9rez-Mu\u00f1oz ME, Haskey N, Silva M, Peerani F, Wong K (2022) Double blind placebo-controlled trial for the prevention of ulcerative colitis relapses by \u03b2-fructan prebiotics: efficacy and metabolomic analysis. Medrxiv:2022.2001. 2016.22269376","DOI":"10.1101\/2022.01.16.22269376"},{"key":"3997_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114009","volume":"180","author":"W Chen","year":"2023","unstructured":"Chen W, Tan D, Yang Z, Tang J, Bai W, Tian L (2023) Fermentation patterns of prebiotics fructooligosaccharides-SCFA esters inoculated with fecal microbiota from ulcerative colitis patients. Food Chem Toxicol 180:114009","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"3997_CR53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2010.232025","volume":"60","author":"JL Benjamin","year":"2011","unstructured":"Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, Stagg AJ, Whelan K, Lindsay JO (2011) Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease. Gut 60(7):923\u2013929. https:\/\/doi.org\/10.1136\/gut.2010.232025","journal-title":"Gut"},{"key":"3997_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103598","author":"B Wilson","year":"2021","unstructured":"Wilson B, Eyice \u00d6 (2021) Prebiotic galactooligosaccharide supplementation in adults with ulcerative colitis: exploring the impact on peripheral blood gene expression, gut microbiota, and clinical symptoms. Nutrients. https:\/\/doi.org\/10.3390\/nu13103598","journal-title":"Nutrients"},{"issue":"3","key":"3997_CR55","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/19490976.2018.1526583","volume":"10","author":"R Valcheva","year":"2019","unstructured":"Valcheva R, Koleva P, Mart\u00ednez I, Walter J, G\u00e4nzle MG (2019) Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Gut Microbes 10(3):334\u2013357. https:\/\/doi.org\/10.1080\/19490976.2018.1526583","journal-title":"Gut Microbes"},{"key":"3997_CR56","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-230x-7-36","volume":"7","author":"A Hafer","year":"2007","unstructured":"Hafer A, Kr\u00e4mer S, Duncker S, Kr\u00fcger M, Manns MP, Bischoff SC (2007) Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol 7:36. https:\/\/doi.org\/10.1186\/1471-230x-7-36","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"3997_CR57","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/apt.17387","volume":"57","author":"S Ikegami","year":"2023","unstructured":"Ikegami S, Nakamura M, Honda T, Yamamura T, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Furune S, Ishikawa T (2023) Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: a randomised, double-blind, placebo-controlled pilot study. Aliment Pharmacol Ther 57(11):1249\u20131257","journal-title":"Aliment Pharmacol Ther"},{"key":"3997_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lwt.2021.111829","volume":"149","author":"Y Peng","year":"2021","unstructured":"Peng Y, Yan Y, Wan P, Chen C, Chen D, Zeng X, Cao Y (2021) Prebiotic effects in vitro of anthocyanins from the fruits of Lycium ruthenicum Murray on gut microbiota compositions of feces from healthy human and patients with inflammatory bowel disease. Lwt 149:111829","journal-title":"Lwt"},{"issue":"12","key":"3997_CR59","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol 52(12):7577\u20137587. https:\/\/doi.org\/10.1007\/s13197-015-1921-1","journal-title":"J Food Sci Technol"},{"key":"3997_CR60","doi-asserted-by":"crossref","unstructured":"Maftei N-M (2019) Probiotic, prebiotic and synbiotic products in human health. Frontiers and new trends in the science of fermented food and beverages, IntechOpen,","DOI":"10.5772\/intechopen.81553"},{"issue":"2","key":"3997_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3920\/BM2019.0076","volume":"11","author":"CQ Calero","year":"2020","unstructured":"Calero CQ, Rinc\u00f3n EO, Marqueta PM (2020) Probiotics, prebiotics and synbiotics: useful for athletes and active individuals? A Syst Rev Beneficial Microbes 11(2):135\u2013149","journal-title":"A Syst Rev Beneficial Microbes"},{"issue":"9","key":"3997_CR62","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/nu13093211","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Zhou D, Gan R, Huang S, Zhao C, Shang A, Xu X (2021) Li H Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: a narrative review. Nutrients 13(9):3211","journal-title":"Nutrients"},{"issue":"3","key":"3997_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/2221-1691.228000","volume":"8","author":"BS Sivamaruthi","year":"2018","unstructured":"Sivamaruthi BS (2018) A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases. Asian Pacific J Trop Biomed 8(3):179","journal-title":"Asian Pacific J Trop Biomed"},{"issue":"4","key":"3997_CR64","first-page":"373","volume":"15","author":"H Steed","year":"2010","unstructured":"Steed H, Macfarlane G, Blackett K (2010) Aliment Pharmacol Ther: clinical trial: the microbiological and immunological effects of synbiotic consumption\u2013a randomized double-blind placebo-controlled study in active Crohn\u2019s disease. Altern Med Rev 15(4):373\u2013374","journal-title":"Altern Med Rev"},{"issue":"1","key":"3997_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.15171\/mejdd.2020.160","volume":"12","author":"T Amiriani","year":"2020","unstructured":"Amiriani T, Rajabli N, Faghani M, Besharat S, Roshandel G, Tabib AA, Joshaghani H (2020) Effect of Lactocare\u00ae synbiotic on disease severity in ulcerative colitis: a randomized placebo-controlled double-blind clinical trial. Middle East J Dig Dis 12(1):27","journal-title":"Middle East J Dig Dis"},{"issue":"4","key":"3997_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5152\/tjg.2019.18356","volume":"30","author":"HK Altun","year":"2019","unstructured":"Altun HK, Y\u0131ld\u0131z EA, Ak\u0131n M (2019) Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: a randomized placebo-controlled study. Turk J Gastroenterol 30(4):313","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"3997_CR67","first-page":"201","volume":"16","author":"H Ishikawa","year":"2011","unstructured":"Ishikawa H, Matsumoto S, Ohashi Y (2011) Digestion: beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Altern Med Rev 16(2):201\u2013202","journal-title":"Altern Med Rev"},{"issue":"1","key":"3997_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-024-05026-9","volume":"22","author":"F Yu","year":"2024","unstructured":"Yu F, Hu X, Ren H, Wang X, Shi R, Guo J, Chang J, Zhou X, Jin Y, Li Y (2024) Protective effect of synbiotic combination of lactobacillus plantarum sc-5 and olive oil extract tyrosol in a murine model of ulcerative colitis. J Transl Med 22(1):308","journal-title":"J Transl Med"},{"issue":"1","key":"3997_CR69","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1038\/s41598-020-80947-1","volume":"11","author":"AM Neyrinck","year":"2021","unstructured":"Neyrinck AM, Rodriguez J, Taminiau B, Amadieu C, Herpin F, Allaert F-A, Cani PD, Daube G, Bindels LB, Delzenne NM (2021) Improvement of gastrointestinal discomfort and inflammatory status by a synbiotic in middle-aged adults: a double-blind randomized placebo-controlled trial. Sci Rep 11(1):2627","journal-title":"Sci Rep"},{"issue":"5","key":"3997_CR70","doi-asserted-by":"publisher","first-page":"ovad057","DOI":"10.1093\/lambio\/ovad057","volume":"76","author":"G Hu","year":"2023","unstructured":"Hu G, Liu S, Zeng H, Yi R, Zhao X, Yang Z (2023) Prevention of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice by a synbiotic approach using probiotic and lactulose. Lett Appl Microbiol 76(5):ovad057","journal-title":"Lett Appl Microbiol"},{"issue":"12","key":"3997_CR71","first-page":"2394","volume":"12","author":"SS Monteiro","year":"2023","unstructured":"Monteiro SS, Schnorr CE, Pasquali MAB (2023) Paraprobiotics and postbiotics-current state of scientific research and future trends toward the development of functional foods. Foods (Basel, Switzerland) 12(12):2394","journal-title":"Foods (Basel, Switzerland)"},{"issue":"4","key":"3997_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4014\/jmb.1911.11019","volume":"30","author":"S Akter","year":"2020","unstructured":"Akter S, Park JH, Jung HK (2020) Potential health-promoting benefits of paraprobiotics, inactivated probiotic cells. J Microbiol Biotechnol 30(4):477\u2013481. https:\/\/doi.org\/10.4014\/jmb.1911.11019","journal-title":"J Microbiol Biotechnol"},{"key":"3997_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041225","author":"RA Siciliano","year":"2021","unstructured":"Siciliano RA, Reale A (2021) Paraprobiotics: a new perspective for functional foods and nutraceuticals. Nutrients. https:\/\/doi.org\/10.3390\/nu13041225","journal-title":"Nutrients"},{"issue":"4","key":"3997_CR74","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/jam.15406","volume":"132","author":"YJ Kye","year":"2022","unstructured":"Kye YJ, Lee SY, Kim HR, Lee BH, Park JH, Park MS, Ji GE, Sung MK (2022) Lactobacillus acidophilus PIN7 paraprobiotic supplementation ameliorates DSS-induced colitis through anti-inflammatory and immune regulatory effects. J Appl Microbiol 132(4):3189\u20133200","journal-title":"J Appl Microbiol"},{"key":"3997_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tifs.2016.09.011","volume":"58","author":"CN de Almada","year":"2016","unstructured":"de Almada CN, Almada CN, Martinez RC, Sant\u2019Ana AS (2016) Paraprobiotics: evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci Technol 58:96\u2013114","journal-title":"Trends Food Sci Technol"},{"key":"3997_CR76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tifs.2018.03.009","volume":"75","author":"J Aguilar-Toal\u00e1","year":"2018","unstructured":"Aguilar-Toal\u00e1 J, Garcia-Varela R, Garcia H, Mata-Haro V, Gonz\u00e1lez-C\u00f3rdova A, Vallejo-Cordoba B, Hern\u00e1ndez-Mendoza A (2018) Postbiotics: an evolving term within the functional foods field. Trends Food Sci Technol 75:105\u2013114","journal-title":"Trends Food Sci Technol"},{"key":"3997_CR77","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3389\/fimmu.2019.02754","volume":"10","author":"E Russo","year":"2019","unstructured":"Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A (2019) Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease. Front Immunol 10:2754","journal-title":"Front Immunol"},{"key":"3997_CR78","doi-asserted-by":"publisher","first-page":"1342705","DOI":"10.3389\/fmicb.2024.1342705","volume":"15","author":"L Bu","year":"2024","unstructured":"Bu L, Li Y, Wang C, Jiang Y, Suo H (2024) Preventive effect of lacticaseibacillus rhamnosus 2016swu. 05.0601 and its postbiotic elements on dextran sodium sulfate-induced colitis in mice. Front Microbiol 15:1342705","journal-title":"Front Microbiol"},{"key":"3997_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134216","volume":"277","author":"FA dos Santos","year":"2024","unstructured":"dos Santos FA, Barroso FAL, Campos GM, Am\u00e9rico MF, dos Santos Viegas RC, Gomes GC, Vital KD, Fernandes SOA, de Oliveira Carvalho RD, Jardin J (2024) Exploring the anti-inflammatory effects of postbiotic proteins from Lactobacillus delbrueckii CIDCA 133 on inflammatory bowel disease model. Int J Biol Macromol 277:134216","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3997_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41538-022-00169-9","volume":"6","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zhang W, Feng C, Kwok L-Y, He Q, Sun Z (2022) Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model. npj Sci Food 6(1):53","journal-title":"npj Sci Food"},{"issue":"6","key":"3997_CR81","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"issue":"8","key":"3997_CR82","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/me.2014-1108","volume":"28","author":"G Clarke","year":"2014","unstructured":"Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG (2014) Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol (Baltimore, Md) 28(8):1221\u20131238. https:\/\/doi.org\/10.1210\/me.2014-1108","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"issue":"6","key":"3997_CR83","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341\u2013352. https:\/\/doi.org\/10.1038\/nri.2016.42","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3997_CR84","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/gutjnl-2013-305283","volume":"63","author":"AD Levin","year":"2014","unstructured":"Levin AD, van den Brink GR (2014) Selective inhibition of mucosal serotonin as treatment for IBD? Gut 63(6):866\u2013867","journal-title":"Gut"},{"issue":"4","key":"3997_CR85","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H (2020) Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Gut 17(4):223\u2013237. https:\/\/doi.org\/10.1038\/s41575-019-0258-z","journal-title":"Gut"},{"key":"3997_CR86","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9706140","author":"X Ding","year":"2020","unstructured":"Ding X, Bin P, Wu W, Chang Y, Zhu G (2020) Tryptophan metabolism, regulatory t cells, and inflammatory bowel disease: a mini review. Med Inflamm. https:\/\/doi.org\/10.1155\/2020\/9706140","journal-title":"Med Inflamm"},{"issue":"6","key":"3997_CR87","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, Rehman A, Tran F, Aden K, H\u00e4sler R, Moll N, Sch\u00fctze G, Schwarz MJ, Waetzig GH, Rosenstiel P, Krawczak M, Szymczak S, Schreiber S (2017) Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153(6):1504-1516.e1502. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.028","journal-title":"Gastroenterology"},{"issue":"1","key":"3997_CR88","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR (2018) Microbial tryptophan catabolites in health and disease. Nat Commun 9(1):3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4","journal-title":"Nat Commun"},{"issue":"1","key":"3997_CR89","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41467-023-43211-4","volume":"14","author":"NT Van","year":"2023","unstructured":"Van NT, Zhang K, Wigmore RM, Kennedy AI, DaSilva CR, Huang J, Ambelil M, Villagomez JH, O\u2019Connor GJ, Longman RS (2023) Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nat Commun 14(1):7363","journal-title":"Nat Commun"},{"key":"3997_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104604","volume":"152","author":"A Bartoszek","year":"2020","unstructured":"Bartoszek A, Moo EV, Binienda A, Fabisiak A, Krajewska JB, Mosi\u0144ska P, Niewinna K, Tarasiuk A, Martemyanov K, Salaga M, Fichna J (2020) Free fatty acid receptors as new potential therapeutic target in inflammatory bowel diseases. Pharmacol Res 152:104604. https:\/\/doi.org\/10.1016\/j.phrs.2019.104604","journal-title":"Pharmacol Res"},{"issue":"2","key":"3997_CR91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.aninu.2017.08.010","volume":"4","author":"A Bedford","year":"2018","unstructured":"Bedford A, Gong J (2018) Implications of butyrate and its derivatives for gut health and animal production. Animal Nutr (Zhongguo xu mu shou yi xue hui) 4(2):151\u2013159. https:\/\/doi.org\/10.1016\/j.aninu.2017.08.010","journal-title":"Animal Nutr (Zhongguo xu mu shou yi xue hui)"},{"issue":"4","key":"3997_CR92","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","volume":"12","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K (2020) The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients 12(4):1107","journal-title":"Nutrients"},{"issue":"10","key":"3997_CR93","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1128\/aem.68.10.5186-5190.2002","volume":"68","author":"SH Duncan","year":"2002","unstructured":"Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ (2002) Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68(10):5186\u20135190. https:\/\/doi.org\/10.1128\/aem.68.10.5186-5190.2002","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"3997_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57(1):1\u201324. https:\/\/doi.org\/10.1007\/s00394-017-1445-8","journal-title":"Eur J Nutr"},{"key":"3997_CR95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen G, Ran X, Li B, Li Y, He D, Huang B, Fu S, Liu J, Wang W (2018) Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30:317\u2013325. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.030","journal-title":"EBioMedicine"},{"key":"3997_CR96","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","volume":"9","author":"T Zuo","year":"2018","unstructured":"Zuo T, Ng SC (2018) The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol 9:2247. https:\/\/doi.org\/10.3389\/fmicb.2018.02247","journal-title":"Front Microbiol"},{"issue":"3","key":"3997_CR97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2036.1995.tb00386.x","volume":"9","author":"P Vernia","year":"1995","unstructured":"Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Paolo MD, Paoluzi P, Torsoli A (1995) Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9(3):309\u2013313","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"3997_CR98","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MEG.0000000000002789","volume":"36","author":"O Ozturk","year":"2024","unstructured":"Ozturk O, Celebi G, Duman UG, Kupcuk E, Uyanik M, Sertoglu E (2024) Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects. Eur J Gastroenterol Hepatol 36(7):890\u2013896","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"3997_CR99","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/00365521.2023.2219357","volume":"58","author":"A Kiasat","year":"2023","unstructured":"Kiasat A, Rautiainen S, Prast-Nielsen S, Engstrand L, Schuppe-Koistinen I, Gustafsson UO, L\u00f6f Granstr\u00f6m A (2023) Evaluation of plasma short chain fatty acid levels as markers for inflammatory bowel disease. Scand J Gastroenterol 58(11):1246\u20131252","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"3997_CR100","first-page":"16254","volume":"132","author":"O Kaczmarczyk","year":"2022","unstructured":"Kaczmarczyk O, D\u0105bek-Drobny A, Wo\u017aniakiewicz M, Pa\u015bko P, Pi\u0105tek-Guziewicz A, Zwoli\u0144ska-Wcis\u0142o M (2022) Altered fecal short-chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and Crohn\u2019s disease: a pilot study. Polish Arch Int Med 132(6):16254","journal-title":"Polish Arch Int Med"},{"issue":"7","key":"3997_CR101","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells10071775","volume":"10","author":"PS Salvi","year":"2021","unstructured":"Salvi PS, Cowles RA (2021) Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells 10(7):1775","journal-title":"Cells"},{"issue":"10","key":"3997_CR102","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/nu10101499","volume":"10","author":"KE Bach Knudsen","year":"2018","unstructured":"Bach Knudsen KE, L\u00e6rke HN, Hedemann MS, Nielsen TS, Ingerslev AK, Gundelund Nielsen DS, Theil PK, Purup S, Hald S, Schioldan AG (2018) Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10(10):1499","journal-title":"Nutrients"},{"key":"3997_CR103","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.2147\/JIR.S300989","volume":"14","author":"MT Siddiqui","year":"2021","unstructured":"Siddiqui MT, Cresci GA (2021) The immunomodulatory functions of butyrate. J Inflamm Res 14:6025\u20136041","journal-title":"J Inflamm Res"},{"issue":"6","key":"3997_CR104","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.clnu.2010.04.002","volume":"29","author":"HM Hamer","year":"2010","unstructured":"Hamer HM, Jonkers DM, Vanhoutvin SA, Troost FJ, Rijkers G, de Bru\u00efne A, Bast A, Venema K, Brummer R-JM (2010) Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 29(6):738\u2013744","journal-title":"Clin Nutr"},{"issue":"8","key":"3997_CR105","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1177\/0091270010379810","volume":"51","author":"SP Perrine","year":"2011","unstructured":"Perrine SP, Wargin WA, Boosalis MS, Wallis WJ, Case S, Keefer JR, Faller DV, Welch WC, Berenson RJ (2011) Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. J Clin Pharmacol 51(8):1186\u20131194. https:\/\/doi.org\/10.1177\/0091270010379810","journal-title":"J Clin Pharmacol"},{"key":"3997_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.662739","volume":"12","author":"MD Carretta","year":"2021","unstructured":"Carretta MD, Quiroga J, L\u00f3pez R, Hidalgo MA, Burgos RA (2021) Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancer. Front Physiol 12:662739","journal-title":"Front Physiol"},{"issue":"1","key":"3997_CR107","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3164\/jcbn.22-86","volume":"73","author":"M Osawa","year":"2023","unstructured":"Osawa M, Handa O, Fukushima S, Matsumoto H, Umegaki E, Inoue R, Naito Y, Shiotani A (2023) Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients. J Clin Biochem Nutr 73(1):77","journal-title":"J Clin Biochem Nutr"},{"issue":"16","key":"3997_CR108","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.3390\/nu14163283","volume":"14","author":"A Pietrzak","year":"2022","unstructured":"Pietrzak A, Banasiuk M, Szczepanik M, Borys-Iwanicka A, Pytrus T, Walkowiak J, Banaszkiewicz A (2022) Sodium butyrate effectiveness in children and adolescents with newly diagnosed inflammatory bowel diseases\u2014randomized placebo-controlled multicenter trial. Nutrients 14(16):3283","journal-title":"Nutrients"},{"issue":"1","key":"3997_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ibd\/izz119","volume":"26","author":"E Ferrer-Pic\u00f3n","year":"2020","unstructured":"Ferrer-Pic\u00f3n E, Dotti I, Corraliza AM, Mayorgas A, Esteller M, Perales JC, Ricart E, Masamunt MC, Carrasco A, Trist\u00e1n E (2020) Intestinal inflammation modulates the epithelial response to butyrate in patients with inflammatory bowel disease. Inflamm Bowel Dis 26(1):43\u201355","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3997_CR110","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1111\/1541-4337.12804","volume":"20","author":"C B\u00fccher","year":"2021","unstructured":"B\u00fccher C, Burtscher J, Domig KJ (2021) Propionic acid bacteria in the food industry: an update on essential traits and detection methods. Compr Rev Food Sci Food Safety 20(5):4299\u20134323","journal-title":"Compr Rev Food Sci Food Safety"},{"issue":"1","key":"3997_CR111","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/fermentation9010026","volume":"9","author":"U Antone","year":"2022","unstructured":"Antone U, Ciprovica I, Zolovs M, Scerbaka R, Liepins J (2022) Propionic acid fermentation\u2014study of substrates, strains, and antimicrobial properties. Fermentation 9(1):26","journal-title":"Fermentation"},{"issue":"20","key":"3997_CR112","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3748\/wjg.v13.i20.2826","volume":"13","author":"S Tedelind","year":"2007","unstructured":"Tedelind S, Westberg F, Kjerrulf M, Vidal A (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol: WJG 13(20):2826","journal-title":"World J Gastroenterol: WJG"},{"issue":"7606","key":"3997_CR113","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature18309","volume":"534","author":"RJ Perry","year":"2016","unstructured":"Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI (2016) Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome. Nature 534(7606):213\u2013217. https:\/\/doi.org\/10.1038\/nature18309","journal-title":"Nature"},{"issue":"12","key":"3997_CR114","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/biom11121903","volume":"11","author":"A Martyniak","year":"2021","unstructured":"Martyniak A, Medy\u0144ska-Prz\u0119czek A, W\u0119drychowicz A, Skocze\u0144 S, Tomasik PJ (2021) Prebiotics, probiotics, synbiotics, paraprobiotics and postbiotic compounds in IBD. Biomolecules 11(12):1903","journal-title":"Biomolecules"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-024-03997-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-03997-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T02:02:29Z","timestamp":1736560949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-024-03997-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s00284-024-03997-y","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12"}}